Center for Noncommunicable Diseases, RTI International, Seattle, Washington, United States of America.
HIV, Health and Development Group, United Nations Development Programme, New York, New York, United States of America.
PLoS One. 2019 Oct 4;14(10):e0223412. doi: 10.1371/journal.pone.0223412. eCollection 2019.
Noncommunicable diseases (NCDs) are a broad challenge for decision-makers. NCDs account for seven out of every 10 deaths globally, with 42 percent occurring prematurely in individuals under age 70. Despite their heavy toll, NCDs are underfunded, with only around two percent of global funding dedicated to the disease set. Country governments are responsible for funding targeted actions to reduce the NCD burden, but among other priorities, many have yet to invest in the health-system interventions and policy measures that can reduce the burden. This article examines "investment cases" as a potential mechanism for catalyzing attention to-and funding for-NCDs. In Jamaica, using the UN inter-agency OneHealth Tool, we conducted an economic analysis to estimate the return-on-investment from scaling up strategic clinical interventions, and from implementing or intensifying policy measures that target NCD risk factors. In addition, we conducted an institutional and context (ICA) analysis, interviewing stakeholders across sectors to take stock of promising policy pathways (e.g., areas of general consensus, political appetite and opportunity) as well as challenges to implementation. The economic analysis found that scaling up clinical interventions that target CVD, diabetes, and mental health disorders, and policy measures that target tobacco and alcohol use, would save over 6,600 lives between 2017-2032, and avert JMD 81.3 billion (USD 640 million) in direct and indirect economic costs that result from mortality and morbidity linked to NCDs. The ICA uncovered government economic growth targets and social priorities that would be aided by increased attention to NCDs, and it linked these targets and priorities to the economic analysis.
非传染性疾病(NCDs)是决策者面临的一个广泛挑战。NCDs 占全球每 10 人死亡的 7 人,其中 42%发生在 70 岁以下的人群中。尽管 NCDs 造成了沉重的负担,但它们的资金投入不足,全球资金中只有约 2%用于该疾病。国家政府负责为减少 NCD 负担的有针对性行动提供资金,但在其他优先事项中,许多国家尚未投资于可以减轻负担的卫生系统干预措施和政策措施。本文探讨了“投资案例”作为引起人们对 NCD 关注和为 NCD 提供资金的潜在机制。在牙买加,我们使用联合国机构间 OneHealth 工具进行了经济分析,以估算扩大战略临床干预措施以及实施或加强针对 NCD 风险因素的政策措施的投资回报。此外,我们还进行了机构和背景(ICA)分析,采访了各个部门的利益相关者,以评估有前途的政策途径(例如,普遍共识、政治意愿和机会等领域)以及实施面临的挑战。经济分析发现,扩大针对 CVD、糖尿病和心理健康障碍的临床干预措施以及针对烟草和酒精使用的政策措施,将在 2017-2032 年间挽救超过 6600 人的生命,并避免 JMD813 亿(6.4 亿美元)与 NCD 相关的死亡和发病导致的直接和间接经济成本。ICA 揭示了政府经济增长目标和社会优先事项,这些目标和优先事项将受益于对 NCD 的更多关注,并将这些目标和优先事项与经济分析联系起来。